Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address big challenges that plague the industry, and why the company is agnostic to drug modality.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
